Will gene augmentation and editing offer the fastest path to broad ocular disease treatment?

Click here to read the Cover Story, "Gene therapy in ocular disease spurs excitement with some caution."

In clinical ophthalmology, we are used to fixing problems on a physical or mechanical level.
This can be through an epiretinal membrane peel, a macular hole closure, laser surgery of any kind, cataract extraction, corneal transplant or even prescribing glasses. But underlying many common ophthalmic problems in ophthalmology are molecular defects or molecular pathways that are being targeted using gene therapy techniques.
The original test bed for gene therapy, with research reaching back 30